{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T04:43:52Z","timestamp":1775537032166,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.pnpbp.2008.10.012","type":"journal-article","created":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T04:46:55Z","timestamp":1225514815000},"page":"94-99","source":"Crossref","is-referenced-by-count":55,"title":["Bipolar I and II disorder residual symptoms: Oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial"],"prefix":"10.1016","volume":"33","author":[{"given":"M.F.","family":"Juruena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.L.","family":"Ottoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Machado-Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Weingarthner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.R.","family":"Marquardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.S.","family":"Fleig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Broilo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.A.","family":"Busnello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2008.10.012_bib1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0006-3223(00)00909-4","article-title":"Historical perspectives and natural history of bipolar disorder","volume":"48","author":"Angst","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.10.012_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2007-1002365","article-title":"Course of schizoaffective psychoses: results of a followup study","volume":"48","author":"Angst","year":"1980","journal-title":"Fortschr Neurol Psychiatr"},{"key":"10.1016\/j.pnpbp.2008.10.012_bib3","first-page":"13","article-title":"The clinical use of carbamazepine in affective disorders","volume":"49 Suppl","author":"Ballenger","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.10.012_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/(SICI)1520-6394(1998)8:2<50::AID-DA2>3.0.CO;2-2","article-title":"Social adjustment and the course of affective illness; a 1-year controlled longitudinal study involving bipolar and unipolar outpatients","volume":"8","author":"Bauwens","year":"1998","journal-title":"Depress Anxiety"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2008.10.012_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0165-0327(02)00407-X","article-title":"Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode","volume":"79","author":"Benedetti","year":"2004","journal-title":"J Affect Disord"},{"issue":"2 Suppl 1","key":"10.1016\/j.pnpbp.2008.10.012_bib6","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.1097\/00004714-199604001-00006","article-title":"Role of newer medications for bipolar disorder","volume":"16","author":"Bowden","year":"1996","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.10.012_bib7","first-page":"245","article-title":"Combined preventive treatment of recurrent manic-depressive disease with lithium and carbamazepine or oxcarbazepine","volume":"58","author":"Cabrera","year":"1987","journal-title":"Nervenarzt"},{"key":"10.1016\/j.pnpbp.2008.10.012_bib31","series-title":"Biological psychiatry in research and clinical application: Mood Disorders","author":"Ceylan","year":"2001"},{"key":"10.1016\/j.pnpbp.2008.10.012_bib8","first-page":"83","article-title":"Studies with oxcarbazepine (trileptal) in acute mania","volume":"5","author":"Emrich","year":"1990","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.10.012_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0091-3057(83)90067-9","article-title":"Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report","volume":"19","author":"Emrich","year":"1983","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2008.10.012_bib10","series-title":"Anticonvulsants in affective disorders","article-title":"Action of sodium-valproate and of oxcarbazepine in patients with affective disorder","author":"Emrich","year":"1984"},{"key":"10.1016\/j.pnpbp.2008.10.012_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0165-0327(85)90022-9","article-title":"The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders","volume":"8","author":"Emrich","year":"1985","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2008.10.012_bib12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archpsyc.1978.01770310043002","article-title":"A diagnostic interview: the schedule for affective disorders and schizophrenia","volume":"35","author":"Endicott","year":"1978","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.10.012_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4088\/JCP.v61n0104","article-title":"The increasing use of polypharmacology for refractory mood disorders: 22\u00a0years of study","volume":"61","author":"Frye","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2008.10.012_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0269881103017002003","article-title":"Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology","volume":"17","author":"Goodwin","year":"2003","journal-title":"J Psychopharmacol"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.10.012_bib15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1017\/S1461145704004651","article-title":"A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder","volume":"7","author":"Hirschfeld","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.10.012_bib16","series-title":"Anticonvulsants in affective disorders","first-page":"139","article-title":"Carbamazepine and oxcarbamazepine in the treatment of manic syndromes: studies in Germany","volume":"vol. 626","author":"Mueller","year":"1984"},{"key":"10.1016\/j.pnpbp.2008.10.012_bib17","series-title":"Oxcarbazepine for the treatment of bipolar disorder, poster presentation","author":"Munoz","year":"2002"},{"key":"10.1016\/j.pnpbp.2008.10.012_bib18","unstructured":"NICE guidelines: Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care guidance type: clinical guideline. www.nice.org.uk\/CG38, 2006."},{"key":"10.1016\/j.pnpbp.2008.10.012_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-1014497","article-title":"Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study","volume":"23","author":"Okuma","year":"1990","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.10.012_bib20","first-page":"29","article-title":"Antidepressant effects of carbamazepine","volume":"43","author":"Post","year":"1986","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.10.012_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000026610","article-title":"Potentiation of antidepressants with lithium or carbamazepine in treatment-resistant depression","volume":"40","author":"Rybakowski","year":"1999","journal-title":"Neuropsychobiology"},{"issue":"10","key":"10.1016\/j.pnpbp.2008.10.012_bib22","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archpsyc.1991.01810340047006","article-title":"Carbamazepine compared with lithium in the treatment of mania","volume":"48","author":"Small","year":"1991","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2008.10.012_bib23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1399-5618.2007.00468.x","article-title":"Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials","volume":"9","author":"Smith","year":"2007","journal-title":"Bipolar Disord"},{"issue":"39","key":"10.1016\/j.pnpbp.2008.10.012_bib24","doi-asserted-by":"crossref","DOI":"10.3310\/hta11390","article-title":"A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder","volume":"11","author":"Soares-Weiser","year":"2007","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.pnpbp.2008.10.012_bib25","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archpsyc.1978.01770300115013","article-title":"Research diagnostic criteria: rationale and reliability","volume":"35","author":"Spitzer","year":"1978","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.10.012_bib26","series-title":"Statistical package for the social sciences for windows, release 15.0","author":"Statistical Package for the Social Sciences for Windows","year":"2006"},{"issue":"CD005171","key":"10.1016\/j.pnpbp.2008.10.012_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005171.pub2","article-title":"Oxcarbazepine in the maintenance treatment of bipolar disorder","volume":"1","author":"Vasudev","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.10.012_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1017\/S1461145708008596","article-title":"A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder","volume":"11","author":"Vieta","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.10.012_bib29","first-page":"89S","article-title":"Case studies on prophylactic long-term effects of oxcarbazepine in recurrent affective disorders","volume":"5","author":"Wildgrube","year":"1990","journal-title":"Int Clin Psychopharmacol"},{"issue":"6","key":"10.1016\/j.pnpbp.2008.10.012_bib30","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1399-5618.2006.00432.x","article-title":"Canadian network for mood and anxiety treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007","volume":"8","author":"Yatham","year":"2006","journal-title":"Bipolar Disord"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608003187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608003187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T14:00:28Z","timestamp":1545660028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584608003187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0278584608003187"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2008.10.012","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}